Cargando…
Incidental Diagnosis in Healthy Clinical Trial Subjects
Previously unrecognized medical conditions identified in volunteers for early phase clinical studies have significant clinical and ethical implications for the participant. It is therefore crucial that the potential for unexpected diagnosis is addressed during the informed consent process. But the f...
Autores principales: | Duncan, Christopher J.A., Rowland, Rosalind, Lillie, Patrick J., Meyer, Joel, Sheehy, Susanne H., O’Hara, Geraldine A., Hamill, Matthew, Donaldson, Hannah, Dinsmore, Laura, Poulton, Ian D., Gilbert, Sarah C., McShane, Helen, Hill, Adrian V.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465775/ https://www.ncbi.nlm.nih.gov/pubmed/22883613 http://dx.doi.org/10.1111/j.1752-8062.2011.00393.x |
Ejemplares similares
-
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines
por: Rowland, Rosalind, et al.
Publicado: (2013) -
Distinguishing malaria and influenza: Early clinical features in controlled human experimental infection studies()
por: Lillie, Patrick J., et al.
Publicado: (2012) -
Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: A phase I clinical trial
por: Rowland, Rosalind, et al.
Publicado: (2013) -
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012) -
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
por: Meyer, Joel, et al.
Publicado: (2013)